Bridgewater Advisors Inc. Sorrento Therapeutics, Inc. Transaction History

Bridgewater Advisors Inc.

  • $959 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$4.65 - $7.23 $102,300 - $159,060
-22,000 Reduced 55.7%
17,500 $81,000
Q3 2021

Nov 02, 2021
BUY
$7.41 - $10.99 $51,870 - $76,930
7,000 Added 21.54%
39,500 $301,000
Q2 2021

Aug 06, 2021
BUY
$6.35 - $10.0 $206,375 - $325,000
32,500 New
32,500 $315,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Bridgewater Advisors Inc. Portfolio

Follow Bridgewater Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email